The trial included over 13,000 people across 30 countries and ran for more than 4.5 years, making it the largest and longest study on tirzepatide so far, the company said ...

Young Americans born in 1990 now face a fourfold higher rectal cancer risk than those born in 1950. Discover the lifestyle factors and health disparities fueling this trend.